Tanvex BioPharma (TPE:6541) Total Inventories : NT$217.84 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Tanvex BioPharma Total Inventories?

Tanvex BioPharma's total inventories for the quarter that ended in Dec. 2024 was NT$217.84 Mil. Tanvex BioPharma's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was NT$174.32 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Tanvex BioPharma's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was NT$-8.26.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tanvex BioPharma's Days Inventory for the three months ended in Dec. 2024 was 11,696.24.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tanvex BioPharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.01.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tanvex BioPharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 62.04.

Tanvex BioPharma Total Inventories Historical Data

The historical data trend for Tanvex BioPharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tanvex BioPharma Total Inventories Chart

Tanvex BioPharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

50.08

90.33

170.84

108.29

217.84

Tanvex BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Inventories	Get a 7-Day Free Trial															108.29	111.18	106.67	130.81	217.84

Tanvex BioPharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Tanvex BioPharma (TPE:6541) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Tanvex BioPharma's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(376.959	+	0.75 * 0.07	+	0.5 * 217.836	-	1841.831
-	0	-	0)	/	164.071
=	-8.26

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tanvex BioPharma's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	174.322	/	1.36	*	365 / 4
	=	11,696.24

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tanvex BioPharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	1.36	/	174.322
	=	0.01

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tanvex BioPharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	174.322	/	2.81
	=	62.04

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Tanvex BioPharma Total Inventories Related Terms

Thank you for viewing the detailed overview of Tanvex BioPharma's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Tanvex BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tanvex BioPharma Inc (TPE:6541) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 376, Ren'ai Road, Section 4, 13th Floor-1, Da'an District, Taipei, TWN, 106

Website

https://www.tanvex.com

Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States.

Tanvex BioPharma Headlines

No Headlines